Stocks · Health care · Biological Products, (No Diagnostic Substances)

Maze Therapeutics, Inc.

MAZE Clue Score57
United States Fiscal year ends December CIK 0001842295 Results filed 11 Aug 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Atul Dandekar
4 May 2026
Csbo
Exercised, kept
5,985
$10.42
$62.36K
Atul Dandekar
4 May 2026
Csbo
Exercised, kept
8,320
$10.42
$86.69K

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 60
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 574,015
History held since 4 Feb 2025